Wednesday, December 07, 2022
name of Prensa Latina
Bandera inglesa
English Edition
name of Prensa Latina

NEWS

BBIL

New Delhi, Aug 15 (Prensa Latina) Bharat Biotech International Limited (BBIL) on Monday announced that its intra-nasal vaccine (BBV154) has proven to be safe, well-tolerated, and immunogenic in subjects in controlled clinical trials.